{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:59:26Z","timestamp":1790366366504,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872687"],"award-info":[{"award-number":["81872687"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573222"],"award-info":[{"award-number":["81573222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR059103"],"award-info":[{"award-number":["R01 AR059103"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 AR073409"],"award-info":[{"award-number":["R61 AR073409"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.autrev.2020.102584","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T13:20:51Z","timestamp":1591795251000},"page":"102584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Pentraxin 3: A promising therapeutic target for autoimmune diseases"],"prefix":"10.1016","volume":"19","author":[{"given":"Qian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Guo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Feng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102584_bb0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2012.02.002","article-title":"Common mechanisms of autoimmune diseases (the autoimmune tautology)","volume":"11","author":"Anaya","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102584_bb0010","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.it.2004.10.006","article-title":"Sex, MHC and complement C4 in autoimmune diseases","volume":"25","author":"Yu","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.autrev.2011.10.022","article-title":"Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?","volume":"11","author":"Costenbader","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102584_bb0020","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1172\/JCI97965","article-title":"Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation","volume":"128","author":"Zou","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102584_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/cmi.2016.60","article-title":"uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K\/Akt signaling pathway in patients with rheumatoid arthritis","volume":"15","author":"Liu","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0030","first-page":"1375","article-title":"Pathologic finding of increased expression of interleukin-17 in the synovial tissue of rheumatoid arthritis patients","volume":"6","author":"Li","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.autrev.2020.102584_bb0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jmcb\/mjs040","article-title":"Polyclonal CD4+Foxp3+ Treg cells induce TGFbeta-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome","volume":"4","author":"Lan","year":"2012","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.autrev.2020.102584_bb0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.autrev.2020.102584_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","article-title":"An integrated view of humoral innate immunity: pentraxins as a paradigm","volume":"28","author":"Bottazzi","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate immunity","volume":"343","author":"Medzhitov","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102584_bb0055","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0051-2016","article-title":"Interplay between myeloid cells and humoral innate immunity","volume":"4","author":"Jaillon","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.autrev.2020.102584_bb0060","series-title":"The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis","first-page":"112","volume":"280","author":"Erreni","year":"2017"},{"key":"10.1016\/j.autrev.2020.102584_bb0065","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","article-title":"Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes","volume":"84","author":"Alles","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2020.102584_bb0070","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20061301","article-title":"The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps","volume":"204","author":"Jaillon","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102584_bb0075","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/rheumatology\/keq005","article-title":"Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease","volume":"49","author":"Breland","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102584_bb0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1152\/physrev.00016.2017","article-title":"PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer","volume":"98","author":"Garlanda","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2020.102584_bb0085","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fimmu.2019.00794","article-title":"The long Pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and Sepsis","volume":"10","author":"Porte","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0090","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.153.4.977","article-title":"Hamster female protein. A new Pentraxin structurally and functionally similar to C-reactive protein and amyloid P component","volume":"153","author":"Coe","year":"1981","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102584_bb0095","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1582-4934.2007.00061.x","article-title":"Role of the soluble pattern recognition receptor PTX3 in vascular biology","volume":"11","author":"Presta","year":"2007","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.autrev.2020.102584_bb0100","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4049\/jimmunol.150.5.1804","article-title":"TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins","volume":"150","author":"Lee","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0105","doi-asserted-by":"crossref","first-page":"22190","DOI":"10.1016\/S0021-9258(18)41653-5","article-title":"Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component","volume":"267","author":"Breviario","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102584_bb0110","doi-asserted-by":"crossref","first-page":"32817","DOI":"10.1074\/jbc.272.52.32817","article-title":"Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component","volume":"272","author":"Bottazzi","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102584_bb0115","doi-asserted-by":"crossref","first-page":"17681","DOI":"10.1074\/jbc.M109.085639","article-title":"The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2","volume":"285","author":"Inforzato","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102584_bb0120","doi-asserted-by":"crossref","first-page":"25584","DOI":"10.1074\/jbc.270.43.25584","article-title":"Promoter structure and transcriptional activation of the murine TSG-14 gene encoding a tumor necrosis factor\/interleukin-1-inducible pentraxin protein","volume":"270","author":"Altmeyer","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102584_bb0125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility","volume":"23","author":"Garlanda","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0130","doi-asserted-by":"crossref","unstructured":"F. Moalli, S. Jaillon, A. Inforzato, M. Sironi, B. Bottazzi, A. Mantovani and C. Garlanda, Pathogen recognition by the long pentraxin PTX3, J Biomed Biotechnol 2011 (2011) 830421.","DOI":"10.1155\/2011\/830421"},{"key":"10.1016\/j.autrev.2020.102584_bb0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-065X.2008.00719.x","article-title":"The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity","volume":"227","author":"Bottazzi","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2020.102584_bb0140","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1189\/jlb.0905493","article-title":"Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma","volume":"79","author":"Doni","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2020.102584_bb0145","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.4049\/jimmunol.172.9.5213","article-title":"Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10","volume":"172","author":"Zheng","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jmcb\/mjt026","article-title":"Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells","volume":"6","author":"Liu","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.autrev.2020.102584_bb0155","article-title":"ITK signalling via the Ras\/IRF4 pathway regulates the development and function of Tr1 cells","volume":"8","author":"Huang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2020.102584_bb0160","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1021\/bi0607453","article-title":"Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation","volume":"45","author":"Inforzato","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.autrev.2020.102584_bb0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/immu.200310022","article-title":"Biochemical and functional characterization of the interaction between pentraxin 3 and C1q","volume":"33","author":"Nauta","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0170","doi-asserted-by":"crossref","first-page":"8650","DOI":"10.1073\/pnas.1304894110","article-title":"Expression of recombinant human complement C1q allows identification of the C1r\/C1s-binding sites","volume":"110","author":"Bally","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102584_bb0175","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1074\/jbc.M110.190637","article-title":"Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system","volume":"286","author":"Ma","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102584_bb0180","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.4049\/jimmunol.181.12.8433","article-title":"Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation","volume":"181","author":"Deban","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000368778","article-title":"The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases","volume":"165","author":"Jaillon","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0190","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.immuni.2011.08.011","article-title":"Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells","volume":"35","author":"Griffith","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2020.102584_bb0195","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2014.00354","article-title":"Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications","volume":"5","author":"Szondy","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1189\/jlb.0805445","article-title":"The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells","volume":"80","author":"Baruah","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2020.102584_bb0205","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V96.13.4300","article-title":"The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells","volume":"96","author":"Rovere","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2020.102584_bb0210","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/art.20370","article-title":"The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages","volume":"50","author":"van Rossum","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102584_bb0215","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/cdd.2008.173","article-title":"Endogenous PTX3 translocates at the membrane of late apoptotic human neutrophils and is involved in their engulfment by macrophages","volume":"16","author":"Jaillon","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.autrev.2020.102584_bb0220","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12975-018-0662-7","article-title":"Post-stroke DHA treatment protects against acute ischemic brain injury by skewing macrophage polarity toward the M2 phenotype","volume":"9","author":"Cai","year":"2018","journal-title":"Transl Stroke Res"},{"issue":"1","key":"10.1016\/j.autrev.2020.102584_bb0225","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12975-019-00694-y","article-title":"Functional dynamics of neutrophils after ischemic stroke","volume":"11","author":"Cai","year":"2020","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.autrev.2020.102584_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1557-6","article-title":"All trans-retinoic acid protects against acute ischemic stroke by modulating neutrophil functions through STAT1 signaling","volume":"16","author":"Cai","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2020.102584_bb0235","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1242\/dev.01056","article-title":"PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization","volume":"131","author":"Salustri","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.autrev.2020.102584_bb0240","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ni.1854","article-title":"Regulation of leukocyte recruitment by the long pentraxin PTX3","volume":"11","author":"Deban","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cytogfr.2013.09.001","article-title":"Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases","volume":"24","author":"Pan","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2020.102584_bb0250","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2016.00604","article-title":"Hall of fame among pro-inflammatory cytokines: Interleukin-6 gene and its transcriptional regulation mechanisms","volume":"7","author":"Luo","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0255","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3389\/fimmu.2018.00784","article-title":"Role of TNF-TNF receptor 2 signal in regulatory T cells and its therapeutic implications","volume":"9","author":"Yang","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0260","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1002\/art.34513","article-title":"Antigen-specific transforming growth factor beta-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17\/Treg cell balance from Th17 predominance to Treg cell predominance","volume":"64","author":"Kong","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102584_bb0265","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2011-201052","article-title":"Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells","volume":"71","author":"Kong","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102584_bb0270","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/cmi.2015.67","article-title":"Inhibition of smoothened decreases proliferation of synoviocytes in rheumatoid arthritis","volume":"14","author":"Zhu","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0275","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fimmu.2018.00702","article-title":"Long non-coding RNA GAPLINC promotes tumor-like biologic behaviors of fibroblast-like synoviocytes as MicroRNA sponging in rheumatoid arthritis patients","volume":"9","author":"Mo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0280","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4049\/jimmunol.146.2.708","article-title":"Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators","volume":"146","author":"Katona","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0285","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.49.10.747","article-title":"Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase","volume":"49","author":"Jose","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102584_bb0290","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/art.1780380406","article-title":"Complement components C1q, C1r\/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures","volume":"38","author":"Breitner","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102584_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102336","article-title":"Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis","volume":"106","author":"Wu","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102584_bb0300","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2249.2000.01110.x","article-title":"Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)","volume":"119","author":"Luchetti","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0305","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopha.2018.06.130","article-title":"Paeoniflorin inhibits rho kinase activation in joint synovial tissues of rats with collagen-induced rheumatoid arthritis","volume":"106","author":"Zhai","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2020.102584_bb0310","first-page":"43","article-title":"Geranylgeranyl-pyrophosphate regulates secretion of pentraxin 3 and monocyte chemoattractant protein-1 from rheumatoid fibroblast-like synoviocytes in distinct manners","volume":"29","author":"Yokota","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0315","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.180.1.203","article-title":"Serum amyloid a is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes","volume":"180","author":"Badolato","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102584_bb0320","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/s10165-012-0630-0","article-title":"Serum amyloid a (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes","volume":"23","author":"Satomura","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0325","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.autrev.2008.01.001","article-title":"The complex immunogenetic basis of systemic lupus erythematosus","volume":"7","author":"Castro","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102584_bb0330","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1038\/emm.2015.37","article-title":"Honokiol ameliorates endothelial dysfunction through suppression of PTX3 expression, a key mediator of IKK\/IkappaB\/NF-kappaB, in atherosclerotic cell model","volume":"47","author":"Qiu","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.autrev.2020.102584_bb0335","first-page":"87","article-title":"Serum pentraxin 3 and interleukin-6 are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis","volume":"17","author":"Mabrouk","year":"2010","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0340","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.carpath.2013.01.007","article-title":"Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritis","volume":"22","author":"Hollan","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.autrev.2020.102584_bb0345","series-title":"Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration","first-page":"681635","author":"Klimek","year":"2014"},{"key":"10.1016\/j.autrev.2020.102584_bb0350","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cca.2018.01.035","article-title":"Acute phase reactant, Pentraxin 3, as a novel marker for the diagnosis of rheumatoid arthritis","volume":"480","author":"Sharma","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2020.102584_bb0355","first-page":"1","article-title":"Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study","author":"Asanuma","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0360","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cyto.2016.04.009","article-title":"Levels of serum pentraxin 3, IL-6, fetuin A and insulin in patients with rheumatoid arthritis","volume":"83","author":"Tekeoglu","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2020.102584_bb0365","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5606\/ArchRheumatol.2018.6394","article-title":"The relationship between serum Pentraxine 3 levels and hematological markers in patients with rheumatoid arthritis","volume":"33","author":"Sag","year":"2018","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0370","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijcard.2016.06.175","article-title":"Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients","volume":"221","author":"Kahlow","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2020.102584_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055346","article-title":"Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: favorable indicators for rheumatoid arthritis activity","volume":"8","author":"Liou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102584_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169830","article-title":"Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis","volume":"12","author":"Deyab","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102584_bb0385","doi-asserted-by":"crossref","first-page":"R224","DOI":"10.1186\/ar3211","article-title":"Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K\/BxN serum-transfer arthritis model","volume":"12","author":"Garcia","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102584_bb0390","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/03009742.2016.1244288","article-title":"Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies","volume":"46","author":"Weitoft","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0395","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrrheum.2014.115","article-title":"Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis","volume":"10","author":"Catrina","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0400","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11033-012-2073-2","article-title":"Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus","volume":"40","author":"Pan","year":"2013","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2020.102584_bb0405","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0961203319829818","article-title":"The essential role of costimulatory molecules in systemic lupus erythematosus","volume":"28","author":"Xiao","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102584_bb0410","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2017.02.011","article-title":"Organ-specific biomarkers in lupus","volume":"16","author":"Wu","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102584_bb0415","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/ken507","article-title":"Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus","volume":"48","author":"Augusto","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102584_bb0420","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2009.117804","article-title":"IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus","volume":"69","author":"Bassi","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102584_bb0425","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaut.2016.07.002","article-title":"Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB\/NZW F1 mice","volume":"74","author":"Gatto","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102584_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020118","article-title":"Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus","volume":"6","author":"Lech","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102584_bb0435","series-title":"Interferon-alpha coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro","first-page":"83","volume":"189","author":"Wirestam","year":"2017"},{"key":"10.1016\/j.autrev.2020.102584_bb0440","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/0004563215578190","article-title":"Sucrose non-fermenting AMPK related kinase\/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients","volume":"53","author":"Zineldeen","year":"2016","journal-title":"Ann Clin Biochem"},{"issue":"2015","key":"10.1016\/j.autrev.2020.102584_bb0445","article-title":"Pentraxin 3 plasma levels and disease activity in systemic lupus erythematosus","author":"Assandri","year":"2015","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.autrev.2020.102584_bb0450","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/14397595.2013.852837","article-title":"Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus","volume":"24","author":"Shimada","year":"2014","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0455","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/08916934.2014.983264","article-title":"Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus","volume":"48","author":"Cieslik","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2020.102584_bb0460","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/0961203317699286","article-title":"Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus","volume":"26","author":"Sahin","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102584_bb0465","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1666-0","article-title":"Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations","volume":"20","author":"Reynolds","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102584_bb0470","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3389\/fimmu.2019.01135","article-title":"PTX3 intercepts vascular inflammation in systemic immune-mediated diseases","volume":"10","author":"Ramirez","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0475","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jbspin.2014.09.003","article-title":"Pentraxin-3 levels in systemic lupus erythematosus: association with cumulative damage but not with disease activity","volume":"82","author":"Skare","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2020.102584_bb0480","series-title":"Endothelial Alterations in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Potential Effect of Monocyte Interaction","first-page":"9680729","author":"Atehortua","year":"2017"},{"key":"10.1016\/j.autrev.2020.102584_bb0485","series-title":"Pentraxin 3 is useful to differentiate infections from flares in patients with systemic lupus erythematosus who present systemic inflammatory response","first-page":"1279","volume":"28","author":"Aragon","year":"2019"},{"key":"10.1016\/j.autrev.2020.102584_bb0490","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2005.11.034","article-title":"Long-term prognosis and causes of death in systemic lupus erythematosus","volume":"119","author":"Doria","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2020.102584_bb0495","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/art.39674","article-title":"A longitudinal analysis of outcomes of lupus nephritis in an international inception cohort using a multistate model approach","volume":"68","author":"Hanly","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0500","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.4049\/jimmunol.170.3.1466","article-title":"The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells","volume":"170","author":"Bussolati","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0505","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12016-015-8476-9","article-title":"PTX3, anti-PTX3, and anti-C1q autoantibodies in lupus glomerulonephritis","volume":"49","author":"Bassi","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0510","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002520","article-title":"Pentraxin 3 is closely associated with Tubulointerstitial injury in lupus nephritis: a large multicenter cross-sectional study","volume":"95","author":"Pang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102584_bb0515","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1523-1755.2005.67111.x","article-title":"Human renal epithelial cells produce the long pentraxin PTX3","volume":"67","author":"Nauta","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2020.102584_bb0520","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2019.00029","article-title":"Circulating Pentraxin3-specific B cells are decreased in lupus nephritis","volume":"10","author":"Gatto","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0525","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102584_bb0530","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2562","article-title":"Developments in the scientific and clinical understanding of the spondyloarthritides","volume":"11","author":"Sieper","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102584_bb0535","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/1756-185X.12779","article-title":"The ongoing quest for biomarkers in Ankylosing spondylitis","volume":"18","author":"Danve","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102584_bb0540","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3899\/jrheum.130803","article-title":"Blood monocyte heterogeneity and markers of endothelial activation in ankylosing spondylitis","volume":"41","author":"Surdacki","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0545","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/acr.20094","article-title":"Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease","volume":"62","author":"Hollan","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2020.102584_bb0550","first-page":"137","article-title":"Levels of pentraxin 3 and relationship with disease activity in patients with ankylosing spondylitis","volume":"39","author":"Deniz","year":"2014","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.autrev.2020.102584_bb0555","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/1354750X.2016.1278265","article-title":"Plasma levels of pentraxin 3 in patients with spondyloarthritis","volume":"23","author":"Nisihara","year":"2018","journal-title":"Biomarkers"},{"key":"10.1016\/j.autrev.2020.102584_bb0560","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/BOR.0000000000000297","article-title":"Ankylosing spondylitis: beyond genome-wide association studies","volume":"28","author":"O\u2019Rielly","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0565","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","article-title":"Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment","volume":"40","author":"Brown","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102584_bb0570","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.12659\/MSM.896562","article-title":"Association of Genetic Variants in Pentraxin 3 Gene with Ankylosing Spondylitis","volume":"22","author":"Zhang","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.autrev.2020.102584_bb0575","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102584_bb0580","first-page":"S66","article-title":"Scleroderma fibroblasts constitutively express the long pentraxin PTX3","volume":"22","author":"Luchetti","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0585","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3899\/jrheum.080343","article-title":"Increased serum pentraxin 3 in patients with systemic sclerosis","volume":"36","author":"Iwata","year":"2009","journal-title":"J Rheumatol"},{"issue":"Suppl. 106","key":"10.1016\/j.autrev.2020.102584_bb0590","first-page":"221","article-title":"Significance of pentraxin-3 in patients with juvenile scleroderma","volume":"35","author":"Adrovic","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl. 113","key":"10.1016\/j.autrev.2020.102584_bb0595","first-page":"102","article-title":"Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function","volume":"36","author":"Kawashiri","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0600","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10067-016-3483-7","article-title":"Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis","volume":"36","author":"Ilgen","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0605","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/art.38953","article-title":"Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis","volume":"67","author":"Shirai","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2020.102584_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130166","article-title":"Systemic sclerosis sera impair angiogenic performance of dermal microvascular endothelial cells: therapeutic implications of cyclophosphamide","volume":"10","author":"Borghini","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102584_bb0615","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/art.27522","article-title":"Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12","volume":"62","author":"Margheri","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102584_bb0620","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2020.102584_bb0625","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1827.2011.02651.x","article-title":"Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis","volume":"61","author":"Savchenko","year":"2011","journal-title":"Pathol Int"},{"key":"10.1016\/j.autrev.2020.102584_bb0630","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1017\/S0022149X13000059","article-title":"Interactions between Trichinella spiralis infection and induced colitis in mice","volume":"88","author":"Ashour","year":"2014","journal-title":"J Helminthol"},{"key":"10.1016\/j.autrev.2020.102584_bb0635","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s10620-007-0075-z","article-title":"Increased expression of long pentraxin PTX3 in inflammatory bowel diseases","volume":"53","author":"Kato","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2020.102584_bb0640","series-title":"Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's Disease","volume":"19","author":"Gaetani","year":"2018"},{"key":"10.1016\/j.autrev.2020.102584_bb0645","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3892\/mmr.2015.3451","article-title":"Serum pentraxin 3 is a novel marker in Crohn\u2019s disease","volume":"12","author":"Chen","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2020.102584_bb0650","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102584_bb0655","doi-asserted-by":"crossref","first-page":"E3246","DOI":"10.1073\/pnas.1421463112","article-title":"Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1","volume":"112","author":"Gao","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102584_bb0660","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1177\/1352458512457845","article-title":"Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica","volume":"19","author":"Wang","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2020.102584_bb0665","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-5728(00)00279-4","article-title":"Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram","volume":"109","author":"Agnello","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0670","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/eji.201545950","article-title":"Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease","volume":"46","author":"Ummenthum","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2020.102584_bb0675","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on psoriasis immunopathogenesis and targeted immunotherapy","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2020.102584_bb0680","first-page":"415","article-title":"Long pentraxin 3: a marker of inflammation in untreated psoriatic patients","volume":"18","author":"Bevelacqua","year":"2006","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.autrev.2020.102584_bb0685","first-page":"3453","article-title":"The levels of serum pentraxin3, CRP, fetuin-A, and insulin in patients with psoriasis","volume":"18","author":"Uysal","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.autrev.2020.102584_bb0690","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jcla.21850","article-title":"Serum Visfatin, Fetuin-a, and Pentraxin 3 levels in patients with psoriasis and their relation to disease severity","volume":"30","author":"Okan","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.autrev.2020.102584_bb0695","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4049\/jimmunol.0802948","article-title":"Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway","volume":"182","author":"Jacob","year":"2009","journal-title":"J Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220301488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220301488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:18:57Z","timestamp":1761599937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220301488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":139,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1568997220301488"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102584","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentraxin 3: A promising therapeutic target for autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102584"}}